Options Brief: Exact Sciences

Shares of Exact Sciences EXAS are higher on the session by 3.72%, trading at $9.19. Overall call volume is now running at 3.60x the daily average, with 82% of all calls traded being purchases on the offer. 1,507 contracts have traded on the session so far. Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. It has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer.